Publication Date:
2020
Abstract:
COVID-19 has rapidly become a major health emergency worldwide. Patients with IBD are at increased risk of infection, especially when they have active disease and are taking immunosuppressive therapy. The characteristics and outcomes of COVID-19 in patients with IBD remain unclear.
CRIS type:
1.1 Articolo in rivista
Keywords:
IBD; epidemiology
List of contributors:
Bezzio, Cristina; Saibeni, Simone; Variola, Angela; Allocca, Mariangela; Massari, Alessandro; Gerardi, Viviana; Casini, Valentina; Ricci, Chiara; Zingone, Fabiana; Amato, Arnaldo; Caprioli, Flavio; Lenti, Marco Vincenzo; Viganò, Chiara; Ascolani, Marta; Bossa, Fabrizio; Castiglione, Fabiana; Cortelezzi, Claudio; Grossi, Laurino; Milla, Monica; Morganti, Daniela; Pastorelli, Luca; Ribaldone, Davide Giuseppe; Sartini, Alessandro; Soriano, Alessandra; Manes, Gianpiero; Danese, Silvio; Fantini, Massimo; Armuzzi, Alessandro; Daperno, Marco; Fiorino, Gionata
Published in: